Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma-Reference-Cited by-同舟云学术

Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma

Published:2016-05-01 Issue:5 Volume:152 Page:527
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Mohan Shalini V.¹,Chang Julia²,Li Shufeng³,Henry A. Solomon⁴,Wood Douglas J.⁴,Chang Anne Lynn S.²

Affiliation:

1. Department of Dermatology, Stanford University School of Medicine, Redwood City, California2currently with Genentech-Roche, South San Francisco, California

2. Department of Dermatology, Stanford University School of Medicine, Redwood City, California

3. Department of Dermatology, Stanford University School of Medicine, Redwood City, California3Department of Urology, Stanford University School of Medicine, Redwood City, California

4. Department of Health Research and Policy, Stanford University School of Medicine, Palo Alto, California

Publisher

American Medical Association (AMA)

Subject

Dermatology

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies;American Journal of Clinical Dermatology;2024-06-19

2. Skin Malignancies Due to Anti-Cancer Therapies;Cancers;2024-05-22

3. Cutaneous Squamous Cell Carcinoma: An Updated Review;Cancers;2024-05-08

4. Management of Locally Advanced Basal Cell Carcinoma with Sonic Hedgehog Pathway Targeted Therapy: A Case Report and Discussion;Case Reports in Dermatology;2024-03-13

5. Cutaneous squamous cell carcinoma of the eyelid in northern latitudes, a 25‐year experience in Finland;Acta Ophthalmologica;2023-12-06